(Q24301293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Manipulation of NK cytotoxicity by the IAP family member Livin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

Baculoviral IAP repeat containing 7

27 December 2019

main subject

cytotoxicity

0 references

1 reference

regulation of natural killer cell apoptotic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

author

Boaz Nachmias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Roi Gazit

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

7

Gal Markel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

9

Ofer Mandelboim

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Sa'ar Mizrahi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Meital Elmalech

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Itay Lazar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Yaqoub Ashhab

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Dina Ben-Yehuda

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

3467-3476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18034418%20AND%20SRC:MED&resulttype=core&format=json

CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

The dialogue between human natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Surface NK receptors and their ligands on tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Killer immunoglobulin-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Granzyme B: a natural born killer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Activation of NK cell cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Natural killer cells in human health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

IAP proteins: blocking the road to death's door

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

RING domains: master builders of molecular scaffolds?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Structural basis of caspase-7 inhibition by XIAP

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Structural basis for the inhibition of caspase-3 by XIAP

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

KIAP, a novel member of the inhibitor of apoptosis protein family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Livin, a novel inhibitor of apoptosis protein family member

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Prognostic value of Survivin and Livin in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Targeting and amplification of immune killing of tumor cells by pro-Smac

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021

Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636600

7 January 2021